HDAC9 and pulmonary arterial hypertension: It has also been identified that oral administration of sodium valproate caused an increase in histone acetylation, leading to effective blockage of RVH induced by PAB or MCT injection, suggesting that HDAC inhibitors might be a potential new therapeutic strategy for RVH secondary to PAH [123].